Great thoughts Jim! As long as the company is making progress I am a supporter. Not worried about timelines and no panic here. Patience is the key with any developing bio company. But if and when it hits the dividends will be plenty.
Nice thoughts and I agree. The initial issue is where they were so far off with milestone schedules when they got close to Stage IV trials and active approvals.
News 
Market Data 
Discover 
